Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms.
- Authors
- Minematsu, N; Nakamura, H; Furuuchi, M; Nakajima, T; Takahashi, S; Tateno, H; Ishizaka, A
- Year
- 2006
- Journal
- The European respiratory journal
- PMID
- 16452582
- DOI
- 10.1183/09031936.06.00056305
The whole gene deletion CYP2A6*4, the defect of the main nicotine oxidase, contributes to limiting lifelong and daily cigarette consumption. However, the effects on smoking habits of CYP2A6*7 and *9, two major functional polymorphisms common in Asian populations, have not been reported. The present study examined the relationship between polymorphisms *4, *7 and *9 with the smoking habits of 200 Japanese smokers who visited the Keio University Hospital (Tokyo, Japan). The allele frequencies of *1 (wild type), *4, *7 and *9 were 52, 17, 11 and 20%, respectively. When the three polymorphisms were considered simultaneously, the percentages of homozygous wild type, heterozygote, and homozygous mutants and compound heterozygotes were 26.0, 52.5 and 21.5%, respectively. Homozygous mutants and compound heterozygotes (n = 43) smoked fewer cigarettes daily than heterozygotes (n = 105) and homozygous wild-type individuals (n = 52). Smokers with *7/*7, *9/*9 or *7/*9 had lower daily cigarette consumption than smokers with *1/*1. In conclusion, polymorphisms *4, *7 and *9 of CYP2A6 were detected in approximately three out of four Japanese smokers, and their daily cigarette consumption was genetically modulated by these functional polymorphisms.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Exploring the impact of ethnicity on drug pharmacokinetics using PBPK models: A case study with lansoprazole in Japanese subjects. | Ezuruike U et al. | — | 2025 | → |
| Socioeconomic Status, Smoking, and Lung Cancer: Mediation and Bias Analysis in the SYNERGY Study. | Hovanec J et al. | — | 2025 | → |
| The Role of Nicotine Metabolic Rate on Nicotine Dependence and Rewarding: Nicotine Metabolism in Chinese Male Smokers and Male Mice. | Liu M et al. | — | 2024 | → |
| Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers. | Perez-Paramo YX et al. | — | 2023 | → |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Perez-Paramo YX et al. | — | 2021 | → |
| Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province. | Cheng Y et al. | — | 2020 | → |
| Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population. | Ezzeldin N et al. | — | 2018 | → |
| Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. | López-Flores LA et al. | — | 2017 | → |
| Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation. | Wang LA et al. | — | 2017 | → |
| Relationship between metabolic phenotypes and genotypes of CYP1A2 and CYP2A6 in the Nigerian population. | Adehin A et al. | — | 2017 | → |
| Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity. | Park SL et al. | — | 2016 | → |
| Genetics of Substance Use Disorders. | Yu C et al. | — | 2016 | → |
| Association of CYP2A6 gene polymorphisms with cigarette consumption: a meta-analysis. | Pan L et al. | — | 2015 | → |
| EFFECT OF CYP2A6*4 GENETIC POLYMORPHISMS ON SMOKING BEHAVIORS AND NICOTINE DEPENDENCE IN A GENERAL POPULATION OF JAPANESE MEN. | Ito T et al. | — | 2015 | → |
| The allele frequency of CYP2A6*4 in four ethnic groups of China. | Pang C et al. | — | 2015 | → |
| The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans. | Bloom AJ et al. | — | 2013 | → |
| PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. | McDonagh EM et al. | — | 2012 | → |
| The genetics of substance dependence. | Wang JC et al. | — | 2012 | → |
| Associations of CYP2A6 genotype with smoking behaviors in southern China. | Liu T et al. | — | 2011 | → |
| Genetic vulnerability and susceptibility to substance dependence. | Bierut LJ | — | 2011 | → |
| The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans. | Bloom J et al. | — | 2011 | → |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | — | 2010 | → |
| Investigation of binding features: effects on the interaction between CYP2A6 and inhibitors. | Ai C et al. | — | 2010 | → |
| A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo. | Al Koudsi N et al. | — | 2009 | → |
| Molecular genetics of nicotine metabolism. | Mwenifumbo JC et al. | — | 2009 | → |
| Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. | Ray R et al. | — | 2009 | → |
| Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent. | Mwenifumbo JC et al. | — | 2008 | → |
| The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer. | Kaida Y et al. | — | 2008 | → |
| Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. | Mwenifumbo JC et al. | — | 2007 | → |
| Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice. | Damaj MI et al. | — | 2007 | → |
| Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking. | Mwenifumbo JC et al. | — | 2007 | → |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | — | 2007 | → |